Join
Live feed
·
INSIDERFilingvia Quantisnow
Gyre Therapeutics Inc. logo

Chief Executive Officer Luo Ying sold $82,927 worth of shares (10,315 units at $8.04) as part of a pre-agreed trading plan (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
GYRE· Gyre Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track GYRE (Gyre Therapeutics Inc.) and more on Quantisnow.